Exxel Pharma, Inc. | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
Exxel Pharma, Inc.

BRIEF

published on 05/01/2024 at 16:05, 6 months 19 days ago

Exxel Pharma to Showcase in Virtual Investor Lunch Break

Exxel Pharma EX937 Virtual Investor Event Chronic Cough Treatment Pharmaceutical Development
BRIEF

published on 05/01/2024 at 16:05, 6 months 19 days ago

Exxel Pharma sera présent lors d'une pause déjeuner virtuelle pour les investisseurs

Exxel Pharma EX937 Événement Virtuel Pour Les Investisseurs Traitement De La Toux Chronique Développement Pharmaceutique
PRESS RELEASE

published on 05/01/2024 at 16:00, 6 months 19 days ago

Exxel Pharma to Participate in the Virtual Investor Lunch Break: The Exxel Opportunity
Soren Mogelsvang, PhD, CEO of Exxel Pharma, to present at Virtual Investor Lunch Break event discussing Exxel opportunity on May 8th. EX937 development updates

Exxel Pharma EX937 Virtual Investor Lunch Break Chronic Cough Treatment Soren Mogelsvang
PRESS RELEASE

published on 01/25/2024 at 16:00, 9 months 26 days ago

Exxel Pharma Provides Business Overview and Upcoming Milestones
Exxel Pharma provided a business overview of its lead program, EX937, an innovative small molecule for treating refractory chronic cough, a condition currently with no FDA-approved therapies. The program demonstrates a differentiated approach with preclinical efficacy and safety, aiming for potential value-driving milestones in 2024 and addressing a large underserved market. The company expects EX937 to have a significant impact on improving the quality of life for adults suffering from chronic cough, with potential broad clinical applications and commercial opportunities.

Exxel Pharma EX937 Refractory Chronic Cough FAA Enzyme Neuronal Hypersensitivity
PRESS RELEASE

published on 10/11/2023 at 16:00, 1 year 1 month ago

Exxel Pharma to Participate in the Virtual Investor Ask the CEO Conference

Accesswire

Published on 11/21/2024 at 09:00, 39 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 4 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 14 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 39 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 39 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 38 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 39 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 39 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 24 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 30 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 41 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 41 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 41 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 32 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 19 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE